Home VistaGen Therapeutics

VistaGen Therapeutics

1 Articles
AECCommercialFinanceINDUSTRY newsLife Science

InterVenn Biosciences Signs Lease for 142,000 SQFT in South San Francisco

By Catherine Sweeney InterVenn Biosciences is expanding its reach across South San Francisco. The company, which focuses its work on glycoprotein analysis, has...

Partner Content

Partner Content


Recent Posts

Social Media Auto Publish Powered By : XYZScripts.com